OneMedNet to Showcase Transformative New Platform at RSNA 2025

Rhea-AI Summary

OneMedNet (Nasdaq: ONMD) will showcase a redesigned data exploration and cohort-building platform at RSNA 2025 after receiving strong validation from customers and prospects at ISPOR Europe on Nov 24, 2025.

The platform, rebuilt on Palantir Foundry and AIP, connects to OneMedNet’s iRWD network covering 2,130+ provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images. Key advances include faster cohort feasibility (minutes vs weeks), AI-driven natural-language search, real-time longitudinal insights, and subscription workflow integration to support recurring revenue.

Attendees are invited to Booth #1742, South Hall, for live demonstrations.

Insights

Commercial Product Strategist

New platform shows strong customer validation, faster cohort feasibility, and deeper dataset scale—commercially positive for recurring‑revenue growth.

OneMedNet reworked its data exploration and cohort‑building platform using Palantir Foundry and AIP, and reported positive live feedback at ISPOR Europe. The platform now connects to an iRWD™ network spanning more than 2,130 provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images, with features that include faster cohort feasibility, AI natural‑language search, and real‑time longitudinal insights.

Commercial impact depends on adoption and monetization of subscription workflows; the release cites tight integration with subscriptions supporting recurring revenue. Key risks include actual customer conversion and sustained usage versus initial demo enthusiasm. Watch adoption metrics, subscription bookings, and retention over the next 12–18 months for concrete commercial validation.

MINNEAPOLIS, Nov. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the curator and provider of the largest global live, regulatory-grade AI-ready Real-World Data (RWD) network today announced strong validation from customers and prospects on its completely redesigned data exploration and cohort-building platform at ISPOR Europe and will showcase this new platform at RSNA in Chicago. 

Executives and scientific leaders from global pharmaceutical companies, contract research organization, and healthcare technology firms participated in live demonstrations at ISPOR. Feedback has been consistently positive of the new user interface and its advanced discovery capabilities, underscoring both the commercial relevance and competitive differentiation of the platform. A senior executive at a leading evidence generation firm summarized the response: “This is transformational — what used to take days of effort now takes minutes, with better accuracy.”

Built on Palantir Foundry and AIP, the platform represents a ground-up reimagination of how research teams interact with OneMedNet’s industry-leading iRWD™ network — now spanning more than 2,130 provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images.

Key advancements include:

• Significantly faster cohort feasibility across de-identified multimodal data
• AI-driven natural-language search for complex discovery tasks
• Real-time availability and longitudinal depth insights
• Tight integration with subscription workflows, supporting recurring-revenue growth

“Our momentum at ISPOR strongly validates the strategy we are executing,” said Aaron Green, President & CEO of OneMedNet. “Customers are now able to determine cohort feasibility in minutes instead of weeks — a transformation made possible only by the scale, speed, and regulatory-grade integrity of our iRWD™ network. This is exactly what the market has been demanding.”

OneMedNet invites attendees at RSNA 2025 to visit Booth #1742, South Hall, for a live demonstration of the new platform.

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 2,130 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial and operational performance, debt reductions, and their effect on achieving operational strategies of the company. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Digital Assets, including Digital Asset’s volatility; and our ability to implement our Digital Asset treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations. Our ability to attract new customers and retain existing customers, market awareness and acceptance of enterprise AI solutions in general and our products in particular, the length and unpredictability of our sales cycles and the time and expense required for our sales efforts.

OneMedNet Contacts:

Michael Wong, VP Marketing

Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

What will OneMedNet (ONMD) present at RSNA 2025 and where is their booth?

OneMedNet will demonstrate its redesigned cohort-building platform at Booth #1742, South Hall during RSNA 2025.

How large is OneMedNet’s iRWD network mentioned in the RSNA 2025 announcement (ONMD)?

The announcement states the iRWD network spans 2,130+ provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images.

What performance improvements did OneMedNet claim for cohort feasibility in the Nov 24, 2025 release (ONMD)?

OneMedNet said customers can determine cohort feasibility in minutes instead of weeks using the redesigned platform.

Which technologies power OneMedNet’s new platform according to the Nov 24, 2025 announcement (ONMD)?

The platform is built on Palantir Foundry and AIP and includes AI-driven natural-language search and real-time longitudinal insights.

Does the OneMedNet platform announcement mention commercial relevance or revenue model (ONMD)?

Yes; the announcement describes tight integration with subscription workflows to support recurring-revenue growth and reports positive customer validation at ISPOR Europe.